You are here:
Home
NICE Guidance
Conditions and diseases
Diabetes and other endocrinal, nutritional and metabolic conditions
Parathyroid disorders
Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy
Technology appraisal guidance
Reference number:
TA117
Published:
24 January 2007
Guidance
Tools and resources
Information for the public
History
Download guidance (PDF)
Overview
1 Guidance
2 Clinical need and practice
3 The technology
4 Evidence and interpretation
5 Implementation
6 Recommendations for further research
7 Related NICE guidance
8 Review of guidance
Appendix A. Appraisal Committee members and NICE project team
Appendix B. Sources of evidence considered by the Committee
Changes after publication
About this guidance
Changes after publication
March 2014:
minor maintenance
March 2012:
minor maintenance
Next page
About this guidance
Previous page
Appendix B. Sources of evidence considered by the Committee